Find therapies in clinical trials near you – page 251

Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

Study on Asciminib and Asciminib Hydrochloride for Patients with Chronic Myelogenous Leukemia in Chronic Phase After Two or More Tyrosine Kinase Inhibitors

Study on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma

Study on the Effects of EVX-01 and Pembrolizumab in Adults with Advanced Melanoma

Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial

Long-Term Safety Study of BI 3720931 for Patients with Cystic Fibrosis from a Previous Trial

Study of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Study of Letetresgene Autoleucel for Patients with Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

Study on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators

Study on the Safety and Effectiveness of BI 3720931 for Adults with Cystic Fibrosis Who Cannot Use CFTR Modulators

Study on Long-Term Safety of Secukinumab for Patients with Polymyalgia Rheumatica

Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

Study of Pertuzumab and Trastuzumab for Patients with Solid Malignant Tumors from Previous Pertuzumab Trials

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Study on the Effects and Safety of Riliprubart for Patients with Chronic Inflammatory Demyelinating Polyneuropathy Unresponsive to Usual Treatments

Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Study of SKB264 for Patients with Advanced Solid Tumors Not Responding to Standard Treatments

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Study on Reduced Dose of Alteplase for Patients with Intermediate-High-Risk Acute Pulmonary Embolism

Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

Study on the Effects of Selpercatinib in Children with Advanced RET-Altered Solid Tumors or Primary Central Nervous System Tumors

Study on Ianalumab for Patients with Systemic Lupus Erythematosus

Study on Ianalumab for Patients with Systemic Lupus Erythematosus